Cytosolic phospholipase A2α-deficient mice are resistant to experimental autoimmune encephalomyelitis

Journal of Experimental Medicine

Volumn 202, Issue 6, 2005, Pages 841-851

  Marusic, Suzana ^a   Leach, Michael W ^a   Pelker, Jeffrey W ^a   Azoitei, Mihai L ^a   Uozumi, Naonori ^b   Cui, Junqing ^a   Shen, Marina W H ^a   DeClercq, Charlene M ^a   Miyashiro, Joy S ^a   Carito, Brenda A ^a   Thakker, Paresh ^a   Simmons, David L ^a   Leonard, John P ^a,c   Shimizu, Takao ^b   Clark, James D ^a  

^a PFIZER INC   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

^c Genzyme Drug Discovery and Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTERASE; INTERLEUKIN 12; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; PHOSPHOLIPASE A2ALPHA; UNCLASSIFIED DRUG; MYELIN ASSOCIATED GLYCOPROTEIN; OLIGODENDROCYTE MYELIN GLYCOPROTEIN; OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; PHOSPHOLIPASE A; PHOSPHOLIPASE A2 ALPHA; PHOSPHOLIPASE A2-ALPHA;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE RESISTANCE; DISEASE SEVERITY; FEMALE; HISTOLOGY; IN VIVO STUDY; KNOCKOUT MOUSE; MOUSE; MOUSE STRAIN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; STRAIN DIFFERENCE; T LYMPHOCYTE; TH1 CELL; WILD TYPE; ANIMAL; C57BL MOUSE; CYTOLOGY; CYTOSOL; ENZYMOLOGY; GENETICS; IMMUNOLOGY; IMMUNOPHENOTYPING; INNATE IMMUNITY; METABOLISM; MOUSE MUTANT; PATHOLOGY; SPINAL CORD;

ANIMALS; CELL DIFFERENTIATION; CYTOSOL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNITY, NATURAL; IMMUNOPHENOTYPING; INTERLEUKIN-12; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELIN-ASSOCIATED GLYCOPROTEIN; PHOSPHOLIPASES A; SPINAL CORD; TH1 CELLS;

EID: 25144519259     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20050665     Document Type: Article

References (59)

1. Zamvil, S.S., and L. Steinman. 1990. The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8:579-621.
2. Martin, R., and H.F. McFarland. 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32:121-182.
3. Steinman, L. 1999. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron. 24:511-514.
4. Steinman, L., R. Martin, C. Bernard, P. Conlon, and J.R. Oksenberg. 2002. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Annu. Rev. Neurosci. 25:491-505.
5. Kuchroo, V.K., C.A. Martin, J.M. Greer, S.T. Ju, R.A. Sobel, and M.E. Dorf. 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encephalomyelitis. J. Immunol. 151:4371-4382.
6. Kennedy, M.K., D.S. Torrance, K.S. Picha, and K.M. Mohler. 1992. Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J. Immunol. 149: 2496-2505.
7. Baron, J.L., J.A. Madri, N.H. Ruddle, G. Hashim, and C.A. Janeway Jr. 1993. Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57-68.
8. Miller, S.D., and W.J. Karpus. 1994. The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases. Immunol. Today. 15:356-361.
9. Steinman, L. 1996. Multiple sclerosis: a coordinated immunological at-tack against myelin in the central nervous system. Cell. 85:299-302.
10. Leonard, J.P., K.E. Waldburger, and S.J. Goldman. 1995. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J. Exp. Med. 181:381-386.
11. Cua, D.J., J. Sherlock, Y. Chen, C.A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature. 421:744-748.
12. Goldberg, R., Y. Zohar, G. Wildbaum, Y. Geron, G. Maor, and N. Karin. 2004. Suppression of ongoing experimental autoimmune encephalomyelitis by neutralizing the function of the p28 subunit of IL-27. J. Immunol. 173:6465-6471.
13. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3:133-146.
14. Szabo, S.J., B.M. Sullivan, S.L. Peng, and L.H. Glimcher. 2003. Molecular mechanisms regulating Th1 immune responses. Annu. Rev. Immunol. 21:713-758.
15. Constantinescu, C.S., M. Wysocka, B. Hilliard, E.S. Ventura, E. Lavi, G. Trinchieri, and A. Rostami. 1998. Antibodies against IL-12 prevent superantigen-induced and spontaneous relapses of experimental autoimmune encephalomyelitis. J. Immunol. 161:5097-5104.
16. Becher, B., B.G. Durell, and R.J. Noelle. 2002. Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12. J. Clin. Invest. 110:493-497.
17. Dore-Duffy, P., and C. Donovan. 1991. Functional desensitization of monocytes from patients with multiple sclerosis due to prostaglandin E. Clin. Immunol. Immunopathol. 61:119-128.
18. Neu, I.S., G. Metzger, J. Zschocke, R. Zelezny, and E. Mayatepek. 2002. Leukotrienes in patients with clinically active multiple sclerosis. Acta Neurol. Scand. 105:63-66.
19. Callea, L., M. Arese, A. Orlandini, C. Bargnani, A. Priori, and F. Bussolino. 1999. Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis. J. Neuroimmunol. 94:212-221.
20. Bonventre, J.V., Z. Huang, M.R. Taheri, E. O'Leary, E. Li, M.A. Moskowitz, and A. Sapirstein. 1997. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2. Nature. 390:622-625.
21. Uozumi, N., K. Kume, T. Nagase, N. Nakatani, S. Ishii, F. Tashiro, Y. Komagata, K. Maki, K. Ikuta, Y. Ouchi, et al. 1997. Role of cytosolic phospholipase A2 in allergic response and parturition. Nature. 390:618-622.
22. Kalyvas, A., and S. David. 2004. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron. 41:323-335.
23. Locati, M., D. Zhou, W. Luini, V. Evangelista, A. Mantovani, and S. Sozzani. 1994. Rapid induction of arachidonic acid release by monocyte chemotactic protein-1 and related chemokines. Role of Ca2+ influx, synergism with platelet-activating factor and significance for chemotaxis. J. Biol. Chem. 269:4746-4753.
24. Murakami, M., Y. Nakatani, G. Atsumi, K. Inoue, and I. Kudo. 1997. Regulatory functions of phospholipase A2. Crit. Rev. Immunol. 17:225-283.
25. Ransohoff, R.M. 1999. Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines. J. Neuroimmunol. 98:57-68.
26. Kudo, I., and M. Murakami. 2002. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 68-69:3-58.
27. Funk, C.D. 2001. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science. 294:1871-1875.
28. McMahon, B., and C. Godson. 2004. Lipoxins: endogenous regulators of inflammation. Am. J. Physiol. Renal Physiol. 286:F189-F201.
29. Serhan, C.N. 2005. Novel omega-3-derived local mediators in antiinflammation and resolution. Pharmacol. Ther. 105:7-21.
30. Huang, J.T., J.S. Welch, M. Ricote, C.J. Binder, T.M. Willson, C. Kelly, J.L. Witztum, C.D. Funk, D. Conrad, and C.K. Glass. 1999. Interleukin-4- dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature. 400:378-382.
31. Niino, M., K. Iwabuchi, S. Kikuchi, M. Ato, T. Morohashi, A. Ogata, K. Tashiro, and K. Onoe. 2001. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by an agonist of peroxisome proliferator-activated receptor-gamma. J. Neuroimmunol. 116:40-48.
32. Riendeau, D., J. Guay, P.K. Weech, F. Laliberte, J. Yergey, C. Li, S. Desmarais, H. Perrier, S. Liu, D. Nicoll-Griffith, et al. 1994. Arachidonyl trifluoromethyl ketone, a potent inhibitor of 85-kDa phospholipase A2, blocks production of arachidonate and 12-hydroxyeicosatetraenoic acid by calcium ionophore-challenged platelets. J. Biol. Chem. 269:15619-15624.
33. Ghomashchi, F., R. Loo, J. Balsinde, F. Bartoli, R. Apitz-Castro, J.D. Clark, E.A. Dennis, and M.H. Gelb. 1999. Trifluoromethyl ketones and methyl fluorophosphonates as inhibitors of group IV and VI phospholipases A(2): structure-function studies with vesicle, micelle, and membrane assays. Biochim. Biophys. Acta. 1420:45-56.
34. Koutek, B., G.D. Prestwich, A.C. Howlett, S.A. Chin, D. Salehani, N. Akhavan, and D.G. Deutsch. 1994. Inhibitors of arachidonoyl ethanolamide hydrolysis. J. Biol. Chem. 269:22937-22940.
35. Fowler, C.J., G. Tiger, and A. Stenstrom. 1997. Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. J. Pharmacol. Exp. Ther. 283:729-734.
36. Croxford, J.L., and S.D. Miller. 2003. Immunoregulation of a viral model of multiple sclerosis using the synthetic cannabinoid R+ WIN55,212. J. Clin. Invest. 111:1231-1240.
37. Amor, S., N. Groome, C. Linington, M.M. Morris, K. Dornmair, M.V. Gardinier, J.M. Matthieu, and D. Baker. 1994. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. J. Immunol. 153:4349-4356.
38. Linington, C., T. Berger, L. Perry, S. Weerth, D. Hinze-Selch, Y. Zhang, H.C. Lu, H. Lassmann, and H. Wekerle. 1993. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system. Eur. J. Immunol. 23:1364-1372.
39. Reese, L., T.J. Carr, R.L. Nicholson, and E.K. Lepp. 1986. Magnetic resonance imaging for detecting lesions of multiple sclerosis: comparison with computed tomography and clinical assessment. CMAJ. 135:639-643.
40. Cross, A.H., B. Cannella, C.F. Brosnan, and C.S. Raine. 1990. Homing to central nervous system vasculature by antigen-specific lymphocytes. I. Localization of 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis. Lab. Invest. 63:162-170.
41. Murphy, P.M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593-633.
42. Tager, A.M., S.K. Bromley, B.D. Medoff, S.A. Islam, S.D. Bercury, E.B. Friedrich, A.C. Carafone, R.E. Gerszten, and A.D. Luster. 2003. Leukotriene B4 receptor BLT1 mediates early effector T cell recruitment. Nat. Immunol. 4:982-990.
43. Goodarzi, K., M. Goodarzi, A.M. Tager, A.D. Luster, and U.H. von Andrian. 2003. Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues. Nat. Immunol. 4:965-973.
44. Ott, V.L., J.C. Camabier, J. Kappler, P. Marrack, and B.J. Swanson. 2003. Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4. Nat. Immunol. 4:974-981.
45. Tager, A.M., and A.D. Luster. 2003. BLT1 and BLT2: the leukotriene B(4) receptors. Prostaglandins Leukot. Essent. Fatty Acids. 69:123-134.
46. Park, T.S., E.R. Gonzales, and J.M. Gidday. 1999. Platelet-activating factor mediates ischemia-induced leukocyte-endothelial adherence in newborn pig brain. J. Cereb. Blood Flow Metab. 19:417-424.
47. Kihara, Y., S. Ishii, Y. Kita, A. Toda, A. Shimada, and T. Shimizu. Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor. J. Exp. Med. 202:853-863.
48. Locati, M., G. Lamorte, W. Luini, M. Introna, S. Bernasconi, A. Mantovani, and S. Sozzani. 1996. Inhibition of monocyte chemotaxis to C-C chemokines by antisense oligonucleotide for cytosolic phospholipase A2. J. Biol. Chem. 271:6010-6016.
49. Tran, E.H., K. Hoekstra, N. van Rooijen, C.D. Dijkstra, and T. Owens. 1998. Immune invasion of the central nervous system parenchyma and experimental allergic encephalomyelitis, but not leukocyte extravasation from blood, are prevented in macrophage-depleted mice. J. Immunol. 161:3767-3775.
50. Reiseter, B.S., G.T. Miller, M.P. Happ, and M.T. Kasaian. 1998. Treatment of murine experimental autoimmune encephalomyelitis with a myelin basic protein peptide analog alters the cellular composition of leukocytes infiltrating the cerebrospinal fluid. J. Neuroimmunol. 91:156-170.
51. Fife, B.T., G.B. Huffnagle, W.A. Kuziel, and W.J. Karpus. 2000. CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis. J. Exp. Med. 192:899-905.
52. Huang, D.R., J. Wang, P. Kivisakk, B.J. Rollins, and R.M. Ransohoff. 2001. Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. J. Exp. Med. 193:713-726.
53. Emerson, M.R., and S.M. LeVine. 2004. Experimental allergic encephalomyelitis is exacerbated in mice deficient for 12/15-lipoxygenase or 5-lipoxygenase. Brain Res. 1021:140-145.
54. Harizi, H., M. Juzan, V. Pitard, J.F. Moreau, and N. Gualde. 2002. Cyclooxygenase-2-issued prostaglandin e(2) enhances the production of endogenous IL-10, which down-regulates dendritic cell functions. J. Immunol. 168:2255-2263.
55. Rieser, C., G. Bock, H. Klocker, G. Bartsch, and M. Thurnher. 1997. Prostaglandin E2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: synergistic activation of interleukin 12 production. J. Exp. Med. 186:1603-1608.
56. Sheibanie, A.F., I. Tadmori, H. Jing, E. Vassiliou, and D. Ganea. 2004. Prostaglandin E2 induces IL-23 production in bone marrow-derived dendritic cells. FASEB J. 18:1318-1320.
57. Hegen, M., L. Sun, N. Uozumi, K. Kume, M.E. Goad, C.L. Nickerson-Nutter, T. Shimizu, and J.D. Clark. 2003. Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis. J. Exp. Med. 197:1297-1302.
58. Sobel, R.A., V.K. Tuohy, Z.J. Lu, R.A. Laursen, and M.B. Lees. 1990. Acute experimental allergic encephalomyelitis in SJL/J mice induced by a synthetic peptide of myelin proteolipid protein. J. Neuropathol. Exp. Neurol. 49:468-479.
59. Sobel, R.A., and V.K. Kuchroo. 1992. The immunopathology of acute experimental allergic encephalomyelitis induced with myelin proteolipid protein. T cell receptors in inflammatory lesions. J. Immunol. 149:1444-1451.